Caplin Point Laboratories Limited has informed the Exchange that Record date for the purpose of Dividend is 30-May-2026.
CAPLIPOINT · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 10.5 pts more than Nifty Smallcap 250 and 10.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Caplin Point Laboratories Board declared an interim dividend of INR 4.00 per equity share (200% on face value of INR 2) for FY 2025-26. The record date for determining shareholder eligibility for the dividend is May 30, 2026. For FY26, the company reported consolidated revenue of INR 2,303 Crores (up 13.2% YoY) and PAT of INR 650 Crores (up 20.1% YoY). US market revenue grew 28.7% YoY to INR 471 Crores. The company has free cash reserves of INR 1,471 Crores and liquid assets of INR 2,726 Crores. The standalone PAT for FY26 was INR 396.58 Crores.
The declaration of a 200% interim dividend signals strong financial health and cash generation, which is positive for shareholders. The substantial free cash reserves provide confidence in the company's ability to sustain dividend payments.